Roche Alecensa delivers unprecedented Phase III results for people with ALK positive early stage lung cancer Ruchika Sharma4 Sept 2023 1:30 PM ISTBasel: Roche has announced that the Phase III ALINA study evaluating Alecensa (alectinib), compared with platinum-based chemotherapy, met its primary...
Novo Nordisk briefly overtakes LVMH as Europe most valuable company Ruchika Sharma4 Sept 2023 12:30 PM ISTLondon: Danish drugmaker Novo Nordisk unseated LVMH as Europe's most valuable listed company on Friday, ending the French luxury group's...
Novartis sues US government over Medicare drug price regulation Ruchika Sharma4 Sept 2023 11:31 AM ISTThe pharmaceutical industry says the program will curtail profits and compel it to pull back on developing new treatments.
Submit scientific justification for increasing patients number in study: CDSCO Tells Eli Lilly on Galcanezumab Dr. Divya Colin3 Sept 2023 6:30 PM ISTNew Delhi: In response to the proposal presented by the drug major Eli Lilly for the protocol amendment of the monoclonal antibody Galcanezumab, the...
AstraZeneca-Daiichi Sankyo Enhertu gets two breakthrough therapy designations in US for multiple HER2 expressing cancers Ruchika Sharma3 Sept 2023 4:00 PM ISTTokyo: Daiichi Sankyo has announced that ENHERTU (fam-trastuzumab deruxtecan-nxki) has been granted two additional Breakthrough Therapy Designations...
Shilpa Pharma Lifesciences Unit II Raichur facility clears PMDA Japan GMP inspection Ruchika Sharma3 Sept 2023 1:15 PM ISTKarnataka: Shilpa Medicare Limited has announced that PMDA, Japan has successfully concluded GMP inspection without any critical/major observation at...
GSK regulatory submission accepted for review by Japanese regulator for Nucala use in adults with chronic rhinosinusitis with nasal polyps Ruchika Sharma3 Sept 2023 12:45 PM ISTLondon: GSK plc has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has accepted for review a supplementary new drug...
India invites bids for privatisation of Indian Medicines Pharmaceutical Ruchika Sharma3 Sept 2023 11:30 AM ISTInterested buyers in Indian Medicines Pharmaceutical should submit initial bids to the government by Oct. 15, according to the government document.
MediBuddy secures Rs 148 crore funding to drive strategic acquisitions, continued expansion Ruchika Sharma2 Sept 2023 2:33 PM ISTKarnataka: MediBuddy, India's digital healthcare platform, secures additional funding of $18 million, reaffirming unwavering support from the existing...
Shilpa Medicare receives UK-MHRA marketing nod for Betahistine Dihydrochloride Orodispersible Films Ruchika Sharma2 Sept 2023 1:30 PM ISTBetahistine is indicated for the treatment of vertigo, tinnitus, hearing loss and nausea associated with Meniere's syndrome and is available as...
Nothing to disclose on Cipla stake buy report, says Torrent Pharma Ruchika Sharma2 Sept 2023 1:00 PM ISTBengaluru: India's Torrent Pharmaceuticals on Friday said it has no information requiring disclosure under listing regulations, after the...
Biocon Generics acquires Eywa Pharma New Jersey facility for Rs 63 crore Ruchika Sharma2 Sept 2023 11:44 AM ISTThe facility has a potential for capacity expansion up to 2 billion tablets/capsules per year.
